Patent · US Active

Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same

US9120872B2 · kind B2 · utility

2Cited by
31References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 27, 2010
Grant dateSep 1, 2015
Priority date
Expiry dateMay 2, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2533/54
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of treating a disorder characterized by tissue damage is provided. The method comprising providing to a subject in need-thereof a composition which comprises a synthetic polymer attached to denatured fibrinogen or a therapeutic portion of the fibrinogen, the composition being formulated for releasing the therapeutic portion of the fibrinogen in a pharmacokinetically regulated manner, thereby treating the disorder characterized by tissue damage or malformation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.